Top Markets
Coin of the day
CinCor Pharma, Inc. CinCor Pharma, Inc.

CinCor Pharma, Inc.

CINC
Pozycja w akcjach #11593
CinCor Pharma, Inc. is an emerging biopharmaceutical firm in the clinical... CinCor Pharma, Inc. is an emerging biopharmaceutical firm in the clinical development phase, dedicated to pioneering therapeutic solutions for cardiovascular and renal conditions. At the core of its pipeline is CIN-107, an investigational compound currently undergoing Phase II clinical trials for indications such as hypertension, primary aldosteronism, and various other cardio-renal disorders. Additionally, CIN-107 is in Phase I clinical evaluation for its potential in treating chronic kidney diseases. The company holds a significant licensing agreement with F. Hoffman-La Roche Ltd. and Hoffmann-La Roche Inc. Established in 2018, CinCor Pharma, Inc. maintains its principal operations in Boston, Massachusetts.
Cena akcji
$29.06
Ostatnia synchronizacja: 2023-02-23
Kapitalizacja rynkowa
$682.73M
Zmiana (1 dzień)
-0.48%
Zmiana (1 rok)
0.00%
Kraj
US
Handel CinCor Pharma, Inc. (CINC)

Kategoria

Historia stopy dywidendy dla CinCor Pharma, Inc. (CINC)
Stopa dywidendy (TTM) dla CinCor Pharma, Inc. (symbol akcji: CINC) na dzień 2026 wynosi: 0
Średnia stopa dywidendy z ostatnich 5 lat: 0.00%
Historia stopy dywidendy dla CinCor Pharma, Inc. (CINC) od 2026 do 2026
Stopa dywidendy na koniec każdego roku (TTM)
Rok Stopa dywidendy Zmień
Za mało danych dla podanych dat.
Stopy dywidendy (TTM) dla podobnych firm lub konkurencji